diclofenac

1. Basic Product Identification

INN Name: Diclofenac

Therapeutic Class: NSAID (Non-copyrightal Anti-Inflammatory Drug)

Common Salts: Diclofenac sodium, Diclofenac potassium

Dosage Forms:

Tablets (IR / SR)

Injectable solution

Topical gels / creams

Suppositories

Key Indications:

Pain & inflammation

Arthritis

Musculoskeletal disorders

Post-operative pain

Migraine (potassium salt fast acting)

2. Therapeutic Knowledge

Diclofenac is widely used for:

Osteoarthritis

Rheumatoid arthritis

Ankylosing spondylitis

Acute musculoskeletal pain

Post-surgical inflammation

Dysmenorrhea

Migraine (acute attack)

3. Mechanism of Action (MOA)

Diclofenac inhibits cyclooxygenase enzymes (COX-1 & COX-2).

Pathway:

↓ COX enzyme activity

↓ prostaglandin synthesis

Effects:

Anti-inflammatory

Analgesic (pain relief)

Antipyretic (fever reduction)

???? COX-2 preference slightly higher than older NSAIDs, but still non-selective.

4. Pharmacokinetics (ADME)

Absorption

Oral bioavailability: ~50–60%

Rapid absorption (especially potassium salt)

Distribution

~99% protein bound (albumin)

Metabolism

Hepatic (CYP2C9 major pathway)

Excretion

Urine (~65%)

Bile/feces (~35%)

Half-life:

1–2 hours (short), but duration extended due to tissue binding

5. Dosage & Administration

Oral:

50 mg 2–3 times daily

SR formulations: 75–100 mg once or twice daily

Injectable:

75 mg IM deep injection

Topical:

1% or 2% gel applied 2–4 times daily

Administration notes:

Take with food to reduce GI irritation

Use lowest effective dose for shortest duration

6. Formulation Knowledge

Oral tablets:

IR / enteric-coated / SR forms

Injectable:

Aqueous solution (often pH-adjusted with buffers)

Topical gels:

Carbomer-based gel systems

Alcohol + penetration enhancers

Key formulation challenges:

Poor water solubility

GI irritation (oral)

Stability in aqueous injectable forms

7. Raw Materials Knowledge

API:

Diclofenac sodium or potassium salt

Excipients:

Microcrystalline cellulose

Lactose / starch

Povidone (binder)

Magnesium stearate

Gel-forming polymers (topical)

Critical raw material concern:

Purity of intermediates (phenylacetic acid derivatives)

Control of impurities (chloroaniline-related)

8. Manufacturing Process Knowledge

API synthesis:

Multi-step organic synthesis:

Phenylacetic acid derivative formation

Chlorination + coupling reactions

Purification via crystallization

Tablet manufacturing:

Granulation (wet or dry)

Compression

Coating (enteric/SR if needed)

Gel manufacturing:

Polymer dispersion

API solubilization

Homogenization

Injectable:

Sterile solution preparation

Filtration (0.22 µm)

Aseptic filling

9. Analytical & QC Knowledge

Key tests:

HPLC assay

Related substances

Dissolution testing

Content uniformity

pH (injectable/topical)

Viscosity (gel)

Stability methods:

Photodegradation studies

Hydrolysis under pH stress

Thermal degradation profiling

10. Regulatory Knowledge

Status:

WHO essential medicine

Globally approved NSAID

Regulatory requirements:

Bioequivalence (oral forms)

Sterile validation (injectables)

Topical dermal absorption studies (gel products)

Label requirements:

GI bleeding risk

Cardiovascular risk warning

Long-term use caution

11. Storage & Stability

Store at 15–25°C

Protect from moisture & light

Stability risks:

Hydrolysis (especially injectable forms)

Photodegradation

Gel viscosity breakdown over time

12. Packaging Knowledge

Oral:

Alu-Alu blister (moisture protection)

Injectable:

Glass ampoules / vials

Topical:

Laminated aluminum tubes

Airless pump containers (premium)

13. Safety & Toxicology

Common side effects:

Gastric irritation

Nausea

Headache

Dizziness

Serious risks:

GI ulcer/bleeding

Cardiovascular thrombotic risk

Liver enzyme elevation

Renal impairment

Contraindications:

Active peptic ulcer

Severe heart disease (long-term use caution)

14. Market & Commercial Knowledge

Market type:

Massive global NSAID market

Competitors:

Ibuprofen

Naproxen

Aceclofenac

Etoricoxib (COX-2 selective)

Strength:

Strong prescription + OTC crossover (topical forms)

15. Intellectual Property (IP)

Original patents expired globally

Highly commoditized generic market

Innovation focus:

Topical delivery systems

Nano-formulations

Sustained release systems

16. Environmental & EHS Knowledge

API synthesis generates chlorinated organic waste

Wastewater treatment required

Gel manufacturing → solvent emissions control

Packaging waste (blisters, tubes)

17. Export Documentation Knowledge

Required documents:

DMF (API + finished product)

GMP certificate

COA (batch-wise)

Stability studies (ICH Q1A)

Validation reports (process + cleaning)

Bioequivalence reports

MSDS

18. Business Development Knowledge

Opportunities:

OTC pain relief segment

Hospital injectable tenders

Topical gel OTC markets (high growth)

Strategy:

Build strong dermatology + orthopedic presence

Focus on topical differentiation (gels, sprays)

Compete on price + brand trust

19. Advanced Technical Knowledge

COX inhibition is reversible and dose-dependent

High protein binding → drug interaction potential

Topical delivery bypasses systemic exposure

Fast potassium salt used for acute pain onset

NSAID class cardiovascular risk mechanism linked to prostaglandin imbalance

20. AI & Digital Knowledge (Modern Pharma)

AI applications:

Pain outcome prediction models

Topical absorption simulation

Supply chain demand forecasting

Pharmacovigilance signal detection (GI/cardiac risk patterns)

Digital pharma:

E-detailing for pain management products

Smart OTC recommendation systems

21. Sales Team Product Knowledge Checklist

Sales teams must know:

Difference between sodium vs potassium forms

GI risk counseling requirement

Short-term vs long-term use guidance

Topical advantage (fewer systemic effects)

Avoid use in high CV-risk patients (long-term)

22. Most Important Technical Documents

DMF (API & formulation)

Bioequivalence study report (oral)

Stability reports diclofenac API Manufacturer in Brasilia (ICH Q1A)

Photostability studies

Sterility validation (injectables)

Process validation reports

Cleaning validation

GMP certificate

23. Ultimate Pharma Product Mastery Summary

Diclofenac is:

A broad-spectrum NSAID with multiple delivery formats

Technically versatile:

Oral, injectable, topical

Commercially powerful:

High global demand in pain management

Manufacturing-critical:

API impurity control

Stability of injectable & gel forms

Leave a Reply

Your email address will not be published. Required fields are marked *